Qube Research & Technologies (QRT)
SCNI

Qube Research & Technologies (QRT)’s Scinai Immunotherapeutics SCNI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$4 – 4606
2024
Q1 		$4 Hold
1
– – ﹤0.01% 4341
2023
Q4 		$4 Hold
1
– – ﹤0.01% 4220
2023
Q3 		$6 Buy
+1
New +$13 ﹤0.01% 3962

Other funds holding SCNI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return
MSG
Main Street Group Glen Allen, Virginia $429M AUM 34.03% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Qube Research & Technologies (QRT)'s SCNI Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Scinai Immunotherapeutics (SCNI) in Q2 2024, closing a stake of 1 share — an estimated $4 sold.

Qube Research & Technologies (QRT) first reported a position in SCNI in Q3 2023 and held it in 3 quarters. The position peaked at $6 in Q3 2023. 9 funds tracked by Wall St. Rank hold SCNI as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Scinai Immunotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1 Scinai Immunotherapeutics share in Q2 2024, an estimated $4.
  • Qube Research & Technologies (QRT) first reported a position in Scinai Immunotherapeutics in Q3 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Scinai Immunotherapeutics position peaked at $6 in Q3 2023.
  • 9 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.